Symbol
| RLN2
| contributors: mct - updated : 29-11-2014
|
HGNC name
| relaxin 2 (H2)
|
HGNC id
| 10027
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in prostate carcinoma | constitutional
|  
|  
| --low
|  
|
in diabetes patients | tumoral
|  
|  
| --over
|  
|
of RLN2 and S100A4 might be related to the prediction of metastasis potency and poor prognosis for osteosarcoma patients | |
Susceptibility
|
to preterm premature rupture of membranes (PPROM) to spontaneous preterm birth (sPTB) |
Variant & Polymorphism
SNP
| rs4742076 was associated significantly with PPROM |
|
SNP rs3758239 was associated with both PPROM and sPTB |
|
|
Candidate gene
Marker
| detection of RLN2 and S100A4 might be useful in evaluating the outcome of patients with osteosarcoma | Therapy target
|
System | Type | Disorder | Pubmed |
cardiovascular | aquired | heart failure | |
may offer therapeutic advantages in end-stage heart failure |
| | |